Neuren Pharmaceuticals | NEU - Market Capitalization

Stock Price
13.20
Daily Change
-0.36 -2.65%
Monthly
-29.82%
Yearly
-5.24%
Q1 Forecast
16.35

Neuren Pharmaceuticals reported AUD1.92B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alaunos Therapeutics USD 5M 2M Sep/2025
Avita Medical AUD 140.79M 194.8M Jun/2025
Clinuvel Pharmaceuticals AUD 520.28M 83.45M Jun/2025
Dianthus Therapeutics USD 1.57B 1000K Feb/2026
Genetic Signatures AUD 82.91M 60.19M Jun/2025
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
Medical Developments International AUD 61.96M 16.34M Jun/2025
Neuren Pharmaceuticals AUD 1.75B 152.5M Jun/2025
Organon & Co USD 2.18B 593.28M Feb/2026
Paradigm Biopharmaceuticals AUD 118.78M 27.21M Jun/2025
PYC Therapeutics AUD 755.32M 139.4M Jun/2025
Tectonic Therapeutic USD 294M 77M Sep/2025
Telix Pharmaceuticals AUD 10.88B 2.64B Jun/2025
Viatris USD 11.54B 1.06B Sep/2025
Xeris Pharmaceuticals USD 1.03B 281M Feb/2026